Traceability Matrix for Process Validation | IVT - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Traceability Matrix for Process Validation | IVT

IVT

Validation Week
SPOTLIGHT EVENT

IVT’s 19th Annual
Validation Week

October 22-24, 2013
San Diego, California

Brochure | Register

RELATED ARTICLES

More in GMPs/Validation


Getty Images

So you’ve followed your validation plan, qualified all the appropriate equipment, and developed, challenged, and placed controls on your process. Installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) is complete. Drawings, procedures have been approved. Training is complete and well-documented. The summary report indicates that all the expected activities and tests were completed successfully and any exceptions have been appropriately resolved.

You’re good to go!

Some time later, maybe years later, an auditor shows up. The questions start. All hands on deck! 

Not surprisingly, by now, many of the original team members have moved on to other positions. Most of the leaders who approved the protocols and reports have transitioned to other responsibilities. The documentation must stand on its own. 

Maybe there are certain links between documents (typically on change history pages), but over time they usually become difficult to follow especially if you’re not one of the document control specialists. So, if probing questions arise, wouldn’t it be great to have a way to find accurate and complete answers quickly? Not a replacement for your technical file, but one document that will bring together all the process development, specifications, testing, etc. that’s aligned with your validation report.

Here is where I see an opportunity to improve many process validation systems. Take a lesson from the computer systems validation (CSV) group. Add a traceability matrix to your documentation. 

Basically a requirement for CSV, traceability matrixes clearly indicate the relationships between user requirements, development specifications, tests, and procedures. A traceability matrix provides a means of linking relevant specifications to testing must be established and maintained. The matrix traces each requirement through design, implementation in the code, and evaluation during testing. Traceability ensures that requirements are met and can be traced to the appropriate configuration/design elements.

And that all the requirements are verified and can be traced to testing or verification activity the shows that the requirement has been met. 

This concept can easily be adopted to show the relationships between production specifications, risk analysis, IQ, OQ, PQ tests, and the procedures established to maintain the validated state of your process. Best of all, it can be navigated by people not intimately familiar with the process to find all the documentation associated with any specific element of that process.

Of course, in practice, each cell in this generic example would be populated with the appropriate document identification number. Be sure to include the version number. Many of the documents will change over time, and you want to refer to the version that was in effect at the time of the validation.

Product Specification

DOE

Critical Input

Controllers

Challenges, Checks, and Balances

Seal Integrity Specification

Critical Inputs
Process Parameters

Heat

Heating Element

IQ

PM

 

Temperature Controller

IQ/OQ

Calibration

 

Temperature Setttings

DOE

DOE

Set-up Sheets

 

Operating Procedures Training

While you could start further back in the development process, it seems to make sense to start with your final product specifications that will be used for manufacturing. Then create a map from each specification through design of experiment (DOE), equipment qualifications, challenge testing, and run documentation. 

At some point, you will be able to create a standard template for the matrix. Then you can use the matrix in two ways. The first would be to show where or how each process element was developed, tested, and controlled. Secondly, it could also be used as an audit tool to clearly show that each element was fully validated.

This article was originally published in IVT - Read the original article here

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: IVT,
Click here